MAP4K4 and liver cancer: The results demonstrated that expression levels of HDAC 1, 2, 3, and 8 were significantly decreased by HGK treatment in a dose-dependent manner (Figures 1C–G), suggesting that HGK was able to inhibit class I HDAC expression in liver cancer cells.